ArticleCureus2025
Extensively Drug-Resistant Tuberculosis With Treatment-Limiting Mood Disorder: A Case of Complex Regimen Selection and Mental Health Challenges.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extensively drug-resistant tuberculosis (XDR-TB) presents a significant therapeutic challenge due to resistance to both first-line and several second-line anti-tuberculosis drugs. Treatment planning becomes even more complex when psychiatric comorbidities and drug hypersensitivities further limit the therapeutic arsenal. This case describes a 41-year-old man with a history of prior incarceration and incompletely treated multidrug-resistant tuberculosis, who presented with pulmonary symptoms and was subsequently diagnosed with XDR-TB. Drug susceptibility testing revealed extensive resistance, including to bedaquiline, clofazimine, and moxifloxacin. A pre-existing mood disorder necessitated the avoidance of neurotoxic agents such as cycloserine, and allergic reactions to several antibiotics led to further regimen modifications. This case underscores the clinical difficulty of managing XDR-TB in the setting of psychiatric illness and drug intolerance. A multidisciplinary, individualized approach was crucial in designing a regimen that strikes a balance between antimicrobial effectiveness and mental health considerations. The patient demonstrated early clinical improvement and was discharged in stable condition with continued outpatient follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.